Cell walls of Mycobacterium leprae, prepared by differential solvent extraction, were shown to contain arabinogalactan, mycolates, and peptidoglycan. In addition, amino acid analysis revealed the unexpected presence of large amounts of protein that retained potent immunological reactivity. Purified cell walls stimulated proliferation of T cells from tuberculoid, but not from lepromatous leprosy, patients and elicited delayed-type hypersensitivity skin reactions in guinea pigs and patients sensitized to M. leprae. Analysis of the precursor frequency of antigen-reactive human peripheral T cells revealed that as many cells (41/6000) proliferate to antigen contained in cell walls as to intact M. keprae. Sequential removal of mycolates and arabinogalactan resulted in a large peptidoglycan-protein complex that retained all the immunological activity. This immunological reactivity and the inherent protein were destroyed by proteolysis. Thus, cell wall protein is a major contributor to cell-mediated immune reactivity to this pathogenic mycobacterium.Leprosy is a chronic infectious disease that afflicts 10-13 million people, primarily living in developing countries (1). Although the incidence of leprosy is declining in many parts of the world, largely due to greater control efforts, the cost of multidrug therapy to combat emergent drug resistance of Mycobacterium leprae is high, and the development of an effective vaccine is widely agreed to offer the best hope for disease eradication (2, 3). Because M. leprae is one of few major pathogens of man that has not been successfully cultivated in vitro, the principal available source of antigens for study and vaccines remains infected tissues of the nine-banded armadillo Dasypus novemcinctus, which is inevitably limited and costly. Consequently, immunological and molecular biological approaches that permit identification and production of protective antigens are needed. Thus far, using murine monoclonal antibodies, genes for six major antigens of M. leprae have been isolated from Agtll libraries (4).From a variety of studies, cell-mediated immunity, which is regulated by specifically sensitized T lymphocytes, is clearly required for protection and resistance to leprosy (1).The disease encompasses an immunological spectrum. At one pole, lepromatous leprosy, patients selectively lack cell-mediated immunity to antigens of M. leprae and fail to restrict the growth of the pathogen; at the tuberculoid end of the spectrum, the patients exhibit cell-mediated immunity to antigens of M. leprae and develop one or a few sharply defined local lesions that contain only few acid-fast bacilli. However, when we and other workers derived M. lepraespecific CD4 + (helper T cell) clones from strongly leprominpositive healthy contacts of lepromatous patients or from blood or lesions of patients with tuberculoid leprosy, only a small proportion of clones tested are responsive to the known serologically defined recombinant antigens (ref. 5; J.M.-K., R.L.M., and B.R.B., unpublished data).For m...